Penn Capital Management Co. Inc. raised its holdings in shares of Innophos Holdings, Inc. (NASDAQ:IPHS) by 16.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 136,180 shares of the specialty chemicals company’s stock after acquiring an additional 19,653 shares during the period. Penn Capital Management Co. Inc. owned about 0.69% of Innophos worth $4,104,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in IPHS. Segall Bryant & Hamill LLC increased its holdings in shares of Innophos by 48.3% during the fourth quarter. Segall Bryant & Hamill LLC now owns 1,707,840 shares of the specialty chemicals company’s stock valued at $41,893,000 after acquiring an additional 556,531 shares in the last quarter. American Century Companies Inc. increased its holdings in shares of Innophos by 24.6% during the fourth quarter. American Century Companies Inc. now owns 905,016 shares of the specialty chemicals company’s stock valued at $22,200,000 after acquiring an additional 178,826 shares in the last quarter. Deprince Race & Zollo Inc. increased its holdings in shares of Innophos by 40.7% during the fourth quarter. Deprince Race & Zollo Inc. now owns 612,289 shares of the specialty chemicals company’s stock valued at $15,019,000 after acquiring an additional 177,149 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in shares of Innophos during the fourth quarter valued at $3,847,000. Finally, D. E. Shaw & Co. Inc. increased its holdings in shares of Innophos by 237.0% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 193,521 shares of the specialty chemicals company’s stock valued at $4,747,000 after acquiring an additional 136,096 shares in the last quarter. 93.41% of the stock is owned by hedge funds and other institutional investors.
Shares of IPHS stock traded up $0.61 during trading hours on Tuesday, reaching $27.95. 52,500 shares of the company traded hands, compared to its average volume of 105,415. Innophos Holdings, Inc. has a 12-month low of $22.57 and a 12-month high of $50.40. The company has a quick ratio of 1.49, a current ratio of 3.14 and a debt-to-equity ratio of 0.95. The stock has a market cap of $537.58 million, a P/E ratio of 12.26 and a beta of 1.41.
The firm also recently declared a quarterly dividend, which was paid on Friday, June 7th. Investors of record on Friday, May 17th were issued a $0.48 dividend. The ex-dividend date was Thursday, May 16th. This represents a $1.92 dividend on an annualized basis and a yield of 6.87%. Innophos’s dividend payout ratio is presently 84.21%.
Several research firms recently commented on IPHS. TheStreet downgraded Innophos from a “b-” rating to a “c+” rating in a report on Thursday, May 23rd. BidaskClub downgraded Innophos from a “hold” rating to a “sell” rating in a research note on Monday, May 20th. Zacks Investment Research upgraded Innophos from a “sell” rating to a “hold” rating in a research note on Tuesday, April 30th. Finally, Seaport Global Securities started coverage on Innophos in a research note on Thursday, February 21st. They set a “buy” rating for the company. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. Innophos has a consensus rating of “Hold”.
TRADEMARK VIOLATION NOTICE: “Penn Capital Management Co. Inc. Increases Stake in Innophos Holdings, Inc. (NASDAQ:IPHS)” was first reported by Mayfield Recorder and is the sole property of of Mayfield Recorder. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://mayfieldrecorder.com/2019/06/11/penn-capital-management-co-inc-has-4-10-million-holdings-in-innophos-holdings-inc-iphs.html.
Innophos Company Profile
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
See Also: Cost of Capital
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.